Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
In the United States, the Centers for Disease Control and Prevention (CDC) reports that over 38.4 million individuals, approximately 11.6% of the population, are currently living with diabetes [2]
The most common ones are: Nausea Vomiting Diarrhea or constipation Mild fatigue Rarely, pancreatitis or gallbladder issues Most of these symptoms are manageable and tend to improve as your body adjusts
As a result, existing players in the GLP-1 market find it increasingly challenging to sustain their market positions amidst growing affordability from generics
marketed for diabetes as Mounjaro and for weight management under trade names such as Zepbound) Tirzepatide combines GLP-1 and GIP receptor agonism and has shown the largest average weight losses of any medication to date
8 9 2 Weighing surgery versus GLP-1s For people with significant obesity, GLP-1 medications and bariatric surgery are sometimes framed as competing options: Pick one or the other
US Department of Health and Human Services
US$ 28.94
US$ 25.12
US$ 25.93
US$ 29.34
US$ 22.79
US$ 29.39
US$ 25.52
